ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01332786
Recruitment Status : Completed
First Posted : April 11, 2011
Last Update Posted : April 15, 2015
Sponsor:
Collaborators:
University of Kansas
Memorial Sloan Kettering Cancer Center
University of California, Los Angeles
Information provided by (Responsible Party):
University Health Network, Toronto

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2014
  Actual Study Completion Date : January 2015